Publications by authors named "Yong-Long Yang"

We aimed to compare the effects of three intensities of treadmill running on exercise-induced hypoalgesia (EIH) in healthy individuals. We anticipated that the primary and secondary changes in pain perception and modulation may differ between running intensities. Sixty-six women were randomly assigned to one of three treadmill running intensities for 35 min: 40% reserved heart rate (HRR), 55% HRR, or 70% HRR.

View Article and Find Full Text PDF
Article Synopsis
  • Acute myeloid leukemia (AML) often has poor outcomes due to chemotherapy resistance, prompting research into genetic factors influencing treatment response.
  • A study identified 32 differentially methylated DNA sites between AML patients who achieved complete remission and those who did not, focusing on nine sites that were further validated in a larger patient group.
  • The gene TBC1D16 was found to be significant; higher expression and methylation levels were linked to poorer prognosis and treatment outcomes, indicating its potential role as a predictor for chemotherapy sensitivity in AML.
View Article and Find Full Text PDF

Background: Lower-grade gliomas (LGGs) is characteristic with great difference in prognosis. Due to limited prognostic biomarkers, it is urgent to identify more molecular markers to provide a more objective and accurate tumor classification system for LGGs.

Methods: In the current study, we performed an integrated analysis of gene expression data and genome-wide methylation data to determine novel prognostic genes and methylation sites in LGGs.

View Article and Find Full Text PDF

Background/aims: In the current study, we performed an integrated analysis of genome-wide methylation and gene expression data to find novel prognostic genes for lower-grade gliomas (LGGs).

Methods: First, TCGA methylation data were used to identify prognostic genes associated with promoter methylation. Second, candidate genes that were stably regulated by promoter methylation were explored.

View Article and Find Full Text PDF

Patients with chronic heart failure (CHF) are often accompanied with varying degrees of renal diseases. The purpose of this study was to identify rs37369 polymorphism of AGXT2 specific to the renal function of CHF patients. A total of 1012 southern Chinese participants, including 487 CHF patients without history of renal diseases and 525 healthy volunteers, were recruited for this study.

View Article and Find Full Text PDF

Background/aims: Acute myeloid leukemia (AML) is a heterogeneous clonal disease and patients with AML who harbor an FMS-like tyrosine kinase 3 (FLT3) mutation present several dilemmas for the clinician. This study aims to identify novel targets for explaining the dilemmas.

Methods: We analyzed four microarray gene expression profiles to investigate changes in whole genome expression associated with FLT3-ITD mutation.

View Article and Find Full Text PDF

Pathological cardiac hypertrophy is an independent risk factor for chronic heart failure. Casein kinase-2 interacting protein-1 (CKIP-1) can inhibit pathological cardiac hypertrophy. Therefore, we investigated whether CKIP-1 nonsynonymous polymorphism rs2306235 (Pro21Ala) contributes to risk and prognosis of chronic heart failure in a Chinese population.

View Article and Find Full Text PDF

Left ventricular remodeling is an essential risk factor contributing to the pathogenesis of chronic heart failure (CHF). Basigin (BSG) promotes cardiovascular inflammation and myocardial remodeling processes by induction of extracellular matrix metalloproteinases and inflammatory cytokines. rs8259 polymorphism was associated with BSG expression and risk of acute coronary syndrome.

View Article and Find Full Text PDF

Whether long non-coding RNA (lncRNA) single-nucleotide polymorphisms (SNPs) affect prognosis of acute myeloid leukemia (AML) remains unknown. To search the association between lncRNA SNPs and AML outcomes, thirty tagSNPs in five lncRNAs were genotyped in 313 AML patients. Survival analysis indicated that GAS5 rs55829688 (T > C) was significantly associated with prognosis of AML (p = 0.

View Article and Find Full Text PDF

Differences in expression of drug response-related genes contribute to inter-individual variation in drugs' biological effects. MicroRNAs (miRNAs) are small noncoding RNAs emerging as new players in epigenetic regulation of gene expression at post-transcriptional level. MiRNAs regulate the expression of genes involved in drug metabolism, drug transportation, drug targets and downstream signal molecules directly or indirectly.

View Article and Find Full Text PDF
Article Synopsis
  • DNMT3A mutations are common in acute myelogenous leukemia (AML), but the impact of its genetic variations on patient outcomes remains unclear.
  • A study of 344 AML patients in southern China identified specific DNMT3A single nucleotide polymorphisms (SNPs) that influenced chemosensitivity and overall survival (OS) rates, with certain SNPs related to increased or decreased effectiveness of chemotherapy.
  • The findings suggest that DNMT3A genetic polymorphisms could serve as potential biomarkers for predicting outcomes in AML patients, potentially enhancing their treatment strategies.
View Article and Find Full Text PDF